Literature DB >> 22664156

Mutational and haplotype map of NOTCH3 in a cohort of Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

S Testi1, G Malerba, M Ferrarini, M Ragno, L Pradotto, A Mauro, G M Fabrizi.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common form of familial vascular dementia, is caused by mutations of the NOTCH3 gene. Approximately two hundred pathogenic mutations have been reported within five exons (exons 3, 4, 6, 11 and 19) which accounted for 78% of known mutations in worldwide series. We reported twenty-one NOTCH3 pathogenic mutations (including five novel ones) identified in 53 index Italian patients. Exons 4 (28%), 7 (21%) and 19 (24%) were the most frequently involved. To dissect genetic heterogeneity, we analyzed five haplotyped tagging single nucleotide polymorphisms (rs1044009, rs4809030, rs10426042, rs10423702 and rs3815188) in 95 patients, 39 unaffected pedigree members and 50 healthy controls. SNPs were analyzed using the Illumina VeraCode Universal Capture Beads technology by Allele Specific Primer Extension (ASPE). We identified ten different haplotypes named H1-H10; H1 was the most common haplotype in patients and controls and it was associated with at least twelve out of the twenty-one mutations. Detected mutations were not associated to specific haplotypes while genotyping was compatible with a possible founder effect for the novel p.S396C mutation which clustered in a restricted geographical area of northeast Italy. The results added on to the genetic heterogeneity of CADASIL and emphasized difficulties in designing algorithms for molecular diagnosis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664156     DOI: 10.1016/j.jns.2012.05.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Two novel mutations in NOTCH3 gene causes cerebral autosomal dominant arteriopathy with subcritical infarct and leucoencephalopathy in two Chinese families.

Authors:  Yuyou Zhu; Juan Wang; Yuanbo Wu; Guoping Wang; Bai Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Notch1 single nucleotide polymorphism rs3124591 is associated with the risk of development of invasive ductal breast carcinoma in a Chinese population.

Authors:  Yu-Wen Cao; Guo-Xing Wan; Chun-Xia Zhao; Jian-Ming Hu; Li Li; Wei-Hua Liang; Wen-Qin Li; Yu-Cong Li; Yi-Xiao Li; Xiao-Ming Du; Shi-Ying Yu; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients.

Authors:  Silvia Bianchi; Enza Zicari; Alessandra Carluccio; Ilaria Di Donato; Francesca Pescini; Serena Nannucci; Raffaella Valenti; Michele Ragno; Domenico Inzitari; Leonardo Pantoni; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2014-10-26       Impact factor: 4.849

4.  Mutation spectrum and genotype-phenotype correlations in 157 Korean CADASIL patients: a multicenter study.

Authors:  Ji-You Min; Seo-Jin Park; Eun-Joo Kang; Seung-Yong Hwang; Sung-Hee Han
Journal:  Neurogenetics       Date:  2021-11-06       Impact factor: 2.660

5.  Mutational screening of NOTCH3 gene reveals two novel mutations: complexity of CADASIL diagnosis.

Authors:  Lorena Mosca; Francesca Rivieri; Raffaella Tanel; Aldo Bonfante; Alessandro Burlina; Emanuela Manfredini; Paola Primignani; Giovanni P Gesu; Alessandro Marocchi; Silvana Penco
Journal:  J Mol Neurosci       Date:  2014-05-10       Impact factor: 3.444

Review 6.  Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases.

Authors:  Dorothee Schoemaker; Joseph F Arboleda-Velasquez
Journal:  Am J Pathol       Date:  2021-04-22       Impact factor: 4.307

7.  Role of electron microscopy in the diagnosis of cadasil syndrome: a study of 32 patients.

Authors:  Manrico Morroni; Daniela Marzioni; Michele Ragno; Paolo Di Bella; Elisabetta Cartechini; Luigi Pianese; Teresa Lorenzi; Mario Castellucci; Marina Scarpelli
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

8.  Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.

Authors:  Tatiana Orme; Dena Hernandez; Owen A Ross; Celia Kun-Rodrigues; Lee Darwent; Claire E Shepherd; Laura Parkkinen; Olaf Ansorge; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; John Q Trojanowski; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda Halliday; David J Stone; Dennis W Dickson; John Hardy; Andrew Singleton; Rita Guerreiro; Jose Bras
Journal:  Acta Neuropathol Commun       Date:  2020-01-29       Impact factor: 7.801

9.  Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases.

Authors:  G Castellani; S Capellari; M Tarozzi; A Bartoletti-Stella; D Dall'Olio; T Matteuzzi; S Baiardi; P Parchi
Journal:  BMC Med Genomics       Date:  2022-02-10       Impact factor: 3.063

10.  Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles.

Authors:  Yi-Chu Liao; Cheng-Tsung Hsiao; Jong-Ling Fuh; Chang-Ming Chern; Wei-Ju Lee; Yuh-Cherng Guo; Shuu-Jiun Wang; I-Hui Lee; Yo-Tsen Liu; Yen-Feng Wang; Feng-Chi Chang; Ming-Hung Chang; Bing-Wen Soong; Yi-Chung Lee
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.